62 related articles for article (PubMed ID: 28830206)
21. JH-4 reduces HMGB1-mediated septic responses and improves survival rate in septic mice.
Lee W; Yuseok O; Yang S; Lee BS; Lee JH; Park EK; Baek MC; Song GY; Bae JS
J Cell Biochem; 2019 Apr; 120(4):6277-6289. PubMed ID: 30378167
[TBL] [Abstract][Full Text] [Related]
22. Suppressive Effects of Ginsenoside Rh1 on HMGB1-Mediated Septic Responses.
Lee W; Cho SH; Kim JE; Lee C; Lee JH; Baek MC; Song GY; Bae JS
Am J Chin Med; 2019; 47(1):119-133. PubMed ID: 30630344
[TBL] [Abstract][Full Text] [Related]
23. Aloin Reduces HMGB1-Mediated Septic Responses and Improves Survival in Septic Mice by Activation of the SIRT1 and PI3K/Nrf2/HO-1 Signaling Axis.
Yang S; Lee W; Lee BS; Lee C; Park EK; Ku SK; Bae JS
Am J Chin Med; 2019; 47(3):613-633. PubMed ID: 30966773
[TBL] [Abstract][Full Text] [Related]
24. Methylthiouracil, a new treatment option for sepsis.
Kwak S; Ku SK; Kang H; Baek MC; Bae JS
Vascul Pharmacol; 2017 Jan; 88():1-10. PubMed ID: 26239884
[TBL] [Abstract][Full Text] [Related]
25. Zingerone reduces HMGB1-mediated septic responses and improves survival in septic mice.
Lee W; Ku SK; Bae JS
Toxicol Appl Pharmacol; 2017 Aug; 329():202-211. PubMed ID: 28610995
[TBL] [Abstract][Full Text] [Related]
26. Sulforaphane Reduces HMGB1-Mediated Septic Responses and Improves Survival Rate in Septic Mice.
Lee IC; Kim DY; Bae JS
Am J Chin Med; 2017; 45(6):1253-1271. PubMed ID: 28830206
[TBL] [Abstract][Full Text] [Related]
27. Targets and mechanisms of sulforaphane derivatives obtained from cruciferous plants with special focus on breast cancer - contradictory effects and future perspectives.
Jabbarzadeh Kaboli P; Afzalipour Khoshkbejari M; Mohammadi M; Abiri A; Mokhtarian R; Vazifemand R; Amanollahi S; Yazdi Sani S; Li M; Zhao Y; Wu X; Shen J; Cho CH; Xiao Z
Biomed Pharmacother; 2020 Jan; 121():109635. PubMed ID: 31739165
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Sulforaphane in Neurodegenerative Diseases.
Schepici G; Bramanti P; Mazzon E
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33207780
[TBL] [Abstract][Full Text] [Related]
29. Targeting HMGB1 in the treatment of sepsis.
Wang H; Ward MF; Sama AE
Expert Opin Ther Targets; 2014 Mar; 18(3):257-68. PubMed ID: 24392842
[TBL] [Abstract][Full Text] [Related]
30. Sulforaphane as anticancer agent: A double-edged sword? Tricky balance between effects on tumor cells and immune cells.
Liang J; Hänsch GM; Hübner K; Samstag Y
Adv Biol Regul; 2019 Jan; 71():79-87. PubMed ID: 30528536
[TBL] [Abstract][Full Text] [Related]
31. Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury.
Deng C; Zhao L; Yang Z; Shang JJ; Wang CY; Shen MZ; Jiang S; Li T; Di WC; Chen Y; Li H; Cheng YD; Yang Y
Acta Pharmacol Sin; 2022 Mar; 43(3):520-528. PubMed ID: 34040166
[TBL] [Abstract][Full Text] [Related]
32. The functional role of sulforaphane in intestinal inflammation: a review.
Wei LY; Zhang JK; Zheng L; Chen Y
Food Funct; 2022 Jan; 13(2):514-529. PubMed ID: 34935814
[TBL] [Abstract][Full Text] [Related]
33. Novel HMGB1-inhibiting therapeutic agents for experimental sepsis.
Wang H; Ward MF; Sama AE
Shock; 2009 Oct; 32(4):348-57. PubMed ID: 19333143
[TBL] [Abstract][Full Text] [Related]
34. Sulforaphane's Multifaceted Potential: From Neuroprotection to Anticancer Action.
Otoo RA; Allen AR
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836745
[TBL] [Abstract][Full Text] [Related]
35. Cruciferous vegetables: rationale for exploring potential salutary effects of sulforaphane-rich foods in patients with chronic kidney disease.
Cardozo LFMF; Alvarenga LA; Ribeiro M; Dai L; Shiels PG; Stenvinkel P; Lindholm B; Mafra D
Nutr Rev; 2021 Oct; 79(11):1204-1224. PubMed ID: 33338213
[TBL] [Abstract][Full Text] [Related]
36. Effects of sulforaphane in the central nervous system.
Huang C; Wu J; Chen D; Jin J; Wu Y; Chen Z
Eur J Pharmacol; 2019 Jun; 853():153-168. PubMed ID: 30858063
[TBL] [Abstract][Full Text] [Related]
37. Emerging role of HMGB1 in fibrotic diseases.
Li LC; Gao J; Li J
J Cell Mol Med; 2014 Dec; 18(12):2331-9. PubMed ID: 25284457
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
